Literature DB >> 6945571

Administration of 3-methylcholanthrene to rats increases the specific hybridizable mRNA coding for cytochrome P-450c.

E Bresnick, M Brosseau, W Levin, L Reik, D E Ryan, P E Thomas.   

Abstract

Poly(A)+-RNA obtained from the livers of 3-methylcholanthrene (3MC)-treated rats was translated into cytochrome P-450c in a cell-free reticulocyte system. In this translational system, no precursor cytochrome P-450c was observed. The mRNA responsible for the synthesis of this cytochrome was isolated by immunoprecipitation of liver polyribosomes obtained at 15 hr after 3MC treatment, and a cDNA was constructed by the reverse transcriptase reaction. The cDNA was further purified by hybridizing at a high R0t (product of RNA concentration and incubation time) to poly(A)+-RNA isolated from control rat liver, and the nonhybridized, single-stranded cDNA was isolated by hydroxylapatite chromatography. This cDNAp-450c was employed in hybridization reactions with poly(A)+-RNA isolated from the livers of rats treated with 3MC for various times. These studies indicated a maximal induction of mRNAp-450c at about 15 hr after 3MC injection, although levels of this mRNA were significantly increased by 7 hr. The mRNAp-450c concentration had diminished by 24 hr but remained higher than control levels for at least 48 hr. These studies establish an effect of 3MC upon the accumulation of mRNAp-450c in rat liver.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6945571      PMCID: PMC319730          DOI: 10.1073/pnas.78.7.4083

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  37 in total

Review 1.  The resolution and reconstitution of the liver microsomal hydroxylation system.

Authors:  A Y Lu; W Levin
Journal:  Biochim Biophys Acta       Date:  1974-09-16

2.  Isolation of hen oviduct ovalbumin and rat live albumin polysomes by indirect immunoprecipitation.

Authors:  D J Shapiro; J M Taylor; G S McKnight; R Palacios; C Gonzalez; M L Kiely; R T Schimke
Journal:  J Biol Chem       Date:  1974-06-25       Impact factor: 5.157

3.  Pharmacological implications of microsomal enzyme induction.

Authors:  A H Conney
Journal:  Pharmacol Rev       Date:  1967-09       Impact factor: 25.468

4.  Purification of ovalbumin messenger ribonucleic acid by specific immunoadsorption of ovalbumin-synthesizing polysomes and millipore partition of ribonucleic acid.

Authors:  R Palacios; D Sullivan; N M Summers; M L Kiely; R T Schimke
Journal:  J Biol Chem       Date:  1973-01-25       Impact factor: 5.157

Review 5.  Cytochrome P-450 and its role in drug metabolism.

Authors:  J R Gillette; D C Davis; H A Sasame
Journal:  Annu Rev Pharmacol       Date:  1972       Impact factor: 13.820

6.  Synthesis of rat liver albumin in a rabbit reticulocyte cell-free protein-synthesizing system.

Authors:  J M Taylor; R T Schimke
Journal:  J Biol Chem       Date:  1973-11-25       Impact factor: 5.157

Review 7.  Drugs and enzyme induction.

Authors:  R Kuntzman
Journal:  Annu Rev Pharmacol       Date:  1969       Impact factor: 13.820

8.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

9.  Properties of cytochrome P-450 as affected by environmental factors: qualitative changes due to administration of polycyclic hydrocarbons.

Authors:  G J Mannering
Journal:  Metabolism       Date:  1971-02       Impact factor: 8.694

10.  Evidence for a new P-450 hemoprotein in hepatic microsomes from methylcholanthrene treated rats.

Authors:  N E Sladek; G J Mannering
Journal:  Biochem Biophys Res Commun       Date:  1966-09-08       Impact factor: 3.575

View more
  8 in total

Review 1.  The induction of microsomal electron transport enzymes.

Authors:  M R Waterman; R W Estabrook
Journal:  Mol Cell Biochem       Date:  1983       Impact factor: 3.396

2.  Regulation of glutathione transferase and DT-diaphorase mRNAs in persistent hepatocyte nodules during chemical hepatocarcinogenesis.

Authors:  C B Pickett; J B Williams; A Y Lu; R G Cameron
Journal:  Proc Natl Acad Sci U S A       Date:  1984-08       Impact factor: 11.205

3.  Induction and repression of the major phenobarbital-induced cytochrome P-450 measured by radioimmunoassay.

Authors:  I R Phillips; E A Shephard; R M Bayney; S F Pike; B R Rabin; R Heath; N Carter
Journal:  Biochem J       Date:  1983-04-15       Impact factor: 3.857

4.  Identification of human cytochromes P-450 analogous to forms induced by phenobarbital and 3-methylcholanthrene in the rat.

Authors:  D J Adams; S Seilman; Z Amelizad; F Oesch; C R Wolf
Journal:  Biochem J       Date:  1985-12-15       Impact factor: 3.857

5.  Camphor hydroxylase of Pseudomonas putida: vestiges of sequence homology in cytochrome P-450CAM, putidaredoxin, and related proteins.

Authors:  K M Dus
Journal:  Proc Natl Acad Sci U S A       Date:  1984-03       Impact factor: 11.205

6.  Persistent induction of cytochrome P450 (CYP)1A enzymes by 3-methylcholanthrene in vivo in mice is mediated by sustained transcriptional activation of the corresponding promoters.

Authors:  Weiwu Jiang; Lihua Wang; Weisheng Zhang; Richard Coffee; Inayat S Fazili; Bhagavatula Moorthy
Journal:  Biochem Biophys Res Commun       Date:  2009-11-11       Impact factor: 3.575

7.  Persistent induction of cytochrome P4501A1 in human hepatoma cells by 3-methylcholanthrene: evidence for sustained transcriptional activation of the CYP1A1 promoter.

Authors:  Inayat S Fazili; Weiwu Jiang; Lihua Wang; Edward A Felix; Tanvir Khatlani; Xavier Coumoul; Robert Barouki; Bhagavatula Moorthy
Journal:  J Pharmacol Exp Ther       Date:  2010-01-05       Impact factor: 4.030

Review 8.  Molecular mechanisms of pulmonary carcinogenesis by polycyclic aromatic hydrocarbons (PAHs): Implications for human lung cancer.

Authors:  Rachel Stading; Grady Gastelum; Chun Chu; Weiwu Jiang; Bhagavatula Moorthy
Journal:  Semin Cancer Biol       Date:  2021-07-07       Impact factor: 15.707

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.